Tiwary Divya, Mukherjee Mala, Deb Roy Asitava, Mondal Himel
Pathology, Mata Gujri Memorial Medical College, Kishanganj, IND.
Pathology, All India Institute of Medical Sciences, Deoghar, Deoghar, IND.
Cureus. 2022 Dec 19;14(12):e32694. doi: 10.7759/cureus.32694. eCollection 2022 Dec.
Background Syringoma is a benign adnexal neoplasm and is considered safe with very low malignant potential. However, multiple tiny lesions typically affect the face and exposed area, which may cause a cosmetic concern for the patient. After a clinical diagnosis, there are two methods to diagnose syringoma: fine needle aspiration cytology (FNAC) and histopathology. FNAC is generally used for the initial evaluation of syringoma, while histopathology is used as a confirmatory test to diagnose syringoma. In developing and resource-limited settings, the combination of FNAC and histopathology would cause a financial and logistics burden. Objective This study aimed to observe the cytological and histopathological features of cases clinically diagnosed as syringomas in a tertiary care hospital to suggest the use of either FNAC or histopathology for diagnosing syringoma. Materials and Methods This cross-sectional observational study was conducted in the Department of Dermatology and Department of Pathology of a tertiary care hospital in eastern India from November 2021 to April 2022. Any clinically provisionally diagnosed case of syringoma was recruited for the study after obtaining informed consent for voluntary participation. With aseptic precautions, the tissue aspirates and punch biopsy were obtained in the Department of Dermatology and the samples were sent to the Department of Pathology. Cytological and histological examination was conducted by a single expert pathologist. Result A total of 50 cases (36 female, 14 male) with a median age of 23 years (range 10-40 years) were included in the study. A total of 43 cases were presented with papular lesions and seven with nodules. In the majority of the cases (40%), the lesion was in the eyelid followed by 26% in the arm. In FNAC, 22 cases were found to be benign adnexal lesions, 16 were suggestive of syringoma, eight were diagnosed as xanthoma, two were diagnosed as warts, and two cases were inadequate for opinion. Histologically, 42 cases were confirmed as syringoma, six were diagnosed as xanthoma, and two cases were diagnosed as warts. There was a significant difference between diagnosis by FNAC and histopathology (McNemar χ = 24.038, p-value = 0.0001). Conclusion We found that FNAC and histopathological diagnosis of syringoma may not be corroborative. Benign adnexal lesions are difficult to categorize by FNAC. Histopathological examination of clinically diagnosed cases of syringoma is of help for definitive diagnosis. Hence, FNAC may be avoided for saving time and discomfort for the patients and clinically diagnosed cases may be diagnosed by histopathological examination.
汗管瘤是一种良性附属器肿瘤,被认为安全性高,恶变潜能极低。然而,多个微小病变通常累及面部和暴露部位,这可能会引起患者的美容问题。临床诊断后,有两种方法可用于诊断汗管瘤:细针穿刺抽吸细胞学检查(FNAC)和组织病理学检查。FNAC一般用于汗管瘤的初步评估,而组织病理学检查则用作诊断汗管瘤的确证性检查。在发展中国家和资源有限的地区,FNAC和组织病理学检查相结合会带来经济和后勤负担。目的:本研究旨在观察一家三级护理医院中临床诊断为汗管瘤的病例的细胞学和组织病理学特征,以建议使用FNAC或组织病理学检查来诊断汗管瘤。材料和方法:这项横断面观察性研究于2021年11月至2022年4月在印度东部一家三级护理医院的皮肤科和病理科进行。在获得自愿参与的知情同意后,招募任何临床初步诊断为汗管瘤的病例进行研究。采取无菌预防措施后,在皮肤科获取组织抽吸物和钻孔活检样本,并将样本送至病理科。由一名专家病理学家进行细胞学和组织学检查。结果:本研究共纳入50例病例(女性36例,男性14例),中位年龄为23岁(范围10 - 40岁)。共有43例表现为丘疹性病变,7例表现为结节。在大多数病例(40%)中,病变位于眼睑,其次是手臂(26%)。在FNAC检查中,发现22例为良性附属器病变,16例提示为汗管瘤,8例诊断为黄瘤,2例诊断为疣,2例样本不足以给出诊断意见。组织学检查中,42例确诊为汗管瘤,6例诊断为黄瘤,2例诊断为疣。FNAC检查和组织病理学检查的诊断结果存在显著差异(McNemar χ = 24.038,p值 = 0.0001)。结论:我们发现汗管瘤的FNAC检查和组织病理学诊断可能不一致。FNAC难以对良性附属器病变进行分类。对临床诊断为汗管瘤的病例进行组织病理学检查有助于明确诊断。因此,为节省患者的时间和不适感,可避免使用FNAC,临床诊断病例可通过组织病理学检查进行诊断。